Cancer Metabolomics

Oncogenomics is a sub field of genomics that portrays disease related qualities. It centers around genomic, epigenomic and transcript adjustments in growth. Malignancy is a hereditary malady caused by assemblage of DNA changes and epigenetic adjustments prompting uncontrolled cell multiplication and neoplasm advancement. The objective of oncogenomics is to recognize new oncogenes or tumor silencer qualities that may give new dreams into disease conclusion, expecting clinical aftereffect of developments and new focuses for malignancy treatments.

    Related Conference of Cancer Metabolomics

    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    Cancer Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in